Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lung

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
Diagnostics (Basel, Switzerland)|August 23, 2020
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)Marc Kovac, Lorenz Risch, Sarah Thiel, et al.
Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.
Biomed Research International|November 23, 2020
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical PresentationMartin Risch, Myriam Weber, Sarah Thiel, et al.
Stroke|May 21, 2021
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial CollaborationGraeme J Hankey, Maree L Hackett, Osvaldo P Almeida, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.
Journal of the American Heart Association|August 5, 2022
Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study FindingsAlexander Chye, Maree L Hackett, Graeme J Hankey, et al.
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Disease Markers|February 3, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 AntibodiesMyriam C Weber, Martin Risch, Sarah L Thiel, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
Diagnostics (Basel, Switzerland)|August 23, 2020
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)Marc Kovac, Lorenz Risch, Sarah Thiel, et al.
Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.
Biomed Research International|November 23, 2020
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical PresentationMartin Risch, Myriam Weber, Sarah Thiel, et al.
Stroke|May 21, 2021
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial CollaborationGraeme J Hankey, Maree L Hackett, Osvaldo P Almeida, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.
Journal of the American Heart Association|August 5, 2022
Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study FindingsAlexander Chye, Maree L Hackett, Graeme J Hankey, et al.
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Disease Markers|February 3, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 AntibodiesMyriam C Weber, Martin Risch, Sarah L Thiel, et al.
Pageof 10